Argyle Capital Management Inc. Amgen Inc Transaction History

Argyle Capital Management Inc.

$240 Million
Q2 2024

A detailed history of Argyle Capital Management Inc. transactions in Amgen Inc stock. As of the latest transaction made, Argyle Capital Management Inc. holds 19,771 shares of AMGN stock, worth $6.32 Million. This represents 2.57% of its overall portfolio holdings.

Number of Shares

19,771

Previous 21,801 9.31%

Holding current value

$6.32 Million

Previous $6.2 Million 0.34%

% of portfolio

2.57%

Previous 2.43%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$262.75 - $319.31 $533,382 - $648,199	-2,030 Reduced 9.31%	19,771 $6.18 Million
Q1 2024 Apr 29, 2024	SELL	$268.87 - $324.56 $207,029 - $249,911	-770 Reduced 3.41%	21,801 $6.2 Million
Q4 2023 Feb 05, 2024	SELL	$255.7 - $288.46 $811,847 - $915,860	-3,175 Reduced 12.33%	22,571 $6.5 Million
Q3 2023 Oct 26, 2023	BUY	$218.65 - $271.46 $163,987 - $203,594	750 Added 3.0%	25,746 $6.92 Million
Q2 2023 Jul 27, 2023	SELL	$214.27 - $253.37 $312,834 - $369,920	-1,460 Reduced 5.52%	24,996 $5.55 Million
Q1 2023 Apr 27, 2023	BUY	$225.79 - $275.2 $11,289 - $13,760	50 Added 0.19%	26,456 $6.4 Million
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $56,799 - $72,170	-248 Reduced 0.93%	26,406 $6.94 Million
Q1 2022 Apr 27, 2022	SELL	$219.27 - $242.57 $175,416 - $194,056	-800 Reduced 2.91%	26,654 $6.45 Million
Q4 2021 Jan 25, 2022	SELL	$198.88 - $227.6 $99,440 - $113,800	-500 Reduced 1.79%	27,454 $6.18 Million
Q3 2021 Oct 25, 2021	SELL	$212.27 - $248.7 $31,840 - $37,305	-150 Reduced 0.53%	27,954 $5.94 Million
Q2 2021 Jul 27, 2021	BUY	$233.58 - $259.14 $46,716 - $51,828	200 Added 0.72%	28,104 $6.85 Million
Q4 2020 Jan 28, 2021	SELL	$216.38 - $257.67 $51,931 - $61,840	-240 Reduced 0.85%	27,904 $6.42 Million
Q3 2020 Oct 27, 2020	SELL	$234.65 - $260.95 $46,930 - $52,190	-200 Reduced 0.71%	28,144 $7.15 Million
Q2 2020 Jul 22, 2020	SELL	$197.81 - $242.74 $59,343 - $72,822	-300 Reduced 1.05%	28,344 $6.69 Million
Q4 2019 Jan 24, 2020	SELL	$189.21 - $243.2 $80,414 - $103,360	-425 Reduced 1.46%	28,644 $6.91 Million
Q3 2019 Oct 25, 2019	SELL	$174.11 - $208.62 $8,705 - $10,431	-50 Reduced 0.17%	29,069 $5.63 Million
Q1 2019 Apr 24, 2019	BUY	$180.87 - $203.88 $27,130 - $30,582	150 Added 0.52%	29,119 $5.53 Million
Q4 2018 Jan 28, 2019	SELL	$178.4 - $208.25 $129,340 - $150,981	-725 Reduced 2.44%	28,969 $5.64 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $24,907 - $27,976	-150 Reduced 0.5%	29,694 $5.48 Million
Q1 2018 Apr 25, 2018	SELL	$169.43 - $198.0 $127,072 - $148,500	-750 Reduced 2.45%	29,844 $5.09 Million
Q4 2017 Jan 25, 2018	SELL	$168.79 - $188.59 $15,191 - $16,973	-90 Reduced 0.29%	30,594 $5.32 Million
Q3 2017 Oct 26, 2017	BUY	$167.29 - $191.0 $5.13 Million - $5.86 Million	30,684	30,684 $5.72 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argyle Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argyle Capital Management Inc. with notifications on news.

Account

Argyle Capital Management Inc. Amgen Inc Transaction History